Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2011 1
2012 1
2013 1
2014 3
2015 2
2016 3
2017 2
2018 2
2019 2
2020 5
2021 6
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 and the Gastrointestinal Tract in Children.
Puoti MG, Rybak A, Kiparissi F, Gaynor E, Borrelli O. Puoti MG, et al. Among authors: kiparissi f. Front Pediatr. 2021 Feb 22;9:617980. doi: 10.3389/fped.2021.617980. eCollection 2021. Front Pediatr. 2021. PMID: 33692973 Free PMC article. Review.
Diagnosing coeliac disease.
Jenkins HR, Murch SH, Beattie RM; Coeliac Disease Working Group of British Society of Paediatric Gastroenterology, Hepatology and Nutrition. Jenkins HR, et al. Arch Dis Child. 2012 May;97(5):393-4. doi: 10.1136/archdischild-2011-301198. Epub 2012 Jan 17. Arch Dis Child. 2012. PMID: 22253278 No abstract available.
STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN.
Pujol-Muncunill G, Navas-López VM, Ledder O, Cohen S, Lekar M, Turner D, Kolho KL, Levine A, Croft NM, Bronsky J, Shouval DS, Assa A, Harris R, Kiparissi F, Aloi M, Afzal NA, Tzivinikos C, Barrio J, Norden C, Vega MJB, Buderus S, de Valderrama AF, de Ridder L, García-Romero R, Medina E, Sánchez C, Velasco M, Vicente S, Wilson DC, Naik S, Hradsky O, Cococcioni L, Martin-de-Carpi J. Pujol-Muncunill G, et al. Among authors: kiparissi f. Eur J Pediatr. 2024 Aug;183(8):3253-3262. doi: 10.1007/s00431-024-05588-2. Epub 2024 May 3. Eur J Pediatr. 2024. PMID: 38700692
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Liu Z, Le K, Zhou X, Alexander JL, Lin S, Bewshea C, Chanchlani N, Nice R, McDonald TJ, Lamb CA, Sebastian S, Kok K, Lees CW, Hart AL, Pollok RC, Boyton RJ, Altmann DM, Pollock KM, Goodhand JR, Kennedy NA, Ahmad T, Powell N; CLARITY study investigators. Liu Z, et al. Lancet Gastroenterol Hepatol. 2023 Feb;8(2):145-156. doi: 10.1016/S2468-1253(22)00389-2. Epub 2022 Dec 5. Lancet Gastroenterol Hepatol. 2023. PMID: 36481043 Free PMC article.
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
Kennedy NA, Goodhand JR, Bewshea C, Nice R, Chee D, Lin S, Chanchlani N, Butterworth J, Cooney R, Croft NM, Hart AL, Irving PM, Kok KB, Lamb CA, Limdi JK, Macdonald J, McGovern DP, Mehta SJ, Murray CD, Patel KV, Pollok RC, Raine T, Russell RK, Selinger CP, Smith PJ, Bowden J, McDonald TJ, Lees CW, Sebastian S, Powell N, Ahmad T; Contributors to the CLARITY IBD study. Kennedy NA, et al. Gut. 2021 May;70(5):865-875. doi: 10.1136/gutjnl-2021-324388. Epub 2021 Mar 22. Gut. 2021. PMID: 33753421
Extraintestinal manifestations in children with gastrointestinal food allergy.
Domínguez-Ortega G, Borrelli O, Meyer R, Dziubak R, De Koker C, Godwin H, Fleming C, Thapar N, Elawad M, Kiparissi F, Fox AT, Shah N. Domínguez-Ortega G, et al. Among authors: kiparissi f. J Pediatr Gastroenterol Nutr. 2014 Aug;59(2):210-4. doi: 10.1097/MPG.0000000000000391. J Pediatr Gastroenterol Nutr. 2014. PMID: 24709825
Developing a core outcome set for fistulising perianal Crohn's disease.
Sahnan K, Tozer PJ, Adegbola SO, Lee MJ, Heywood N, McNair AGK, Hind D, Yassin N, Lobo AJ, Brown SR, Sebastian S, Phillips RKS, Lung PFC, Faiz OD, Crook K, Blackwell S, Verjee A, Hart AL, Fearnhead NS; ENiGMA collaborators. Sahnan K, et al. Gut. 2019 Feb;68(2):226-238. doi: 10.1136/gutjnl-2017-315503. Epub 2018 Feb 3. Gut. 2019. PMID: 29437911 Free PMC article.
Safety and Efficacy of Split-Dose Thiopurine vs Low-Dose Thiopurine-Allopurinol Cotherapy in Pediatric Inflammatory Bowel Disease.
Cococcioni L, Pensabene L, Puoti MG, El-Kouly S, Chadokufa S, Buckingham R, Gaynor E, Saliakellis E, Kiparissi F, Borrelli O. Cococcioni L, et al. Among authors: kiparissi f. Clin Transl Gastroenterol. 2023 Mar 1;14(3):e00544. doi: 10.14309/ctg.0000000000000544. Clin Transl Gastroenterol. 2023. PMID: 36729814 Free PMC article.
Transition Services for Paediatric Inflammatory Bowel Disease: A Multicentre Study of Practice in the United Kingdom.
Ashton JJ, Narula P, Kiparissi F, Spray C, Wilson DC, Tayler R, Howarth L, Torrente F, Deb P, Cameron FL, Muhammed R, Paul T, Epstein J, Lawson M, Maginnis J, Zamvar V, Fagbemi A, Devadason D, Bhavsar HS, Kammermeier J, Beattie RM. Ashton JJ, et al. Among authors: kiparissi f. J Pediatr Gastroenterol Nutr. 2021 Aug 1;73(2):251-258. doi: 10.1097/MPG.0000000000003148. J Pediatr Gastroenterol Nutr. 2021. PMID: 33853108
Phosphomannomutase 2 (PMM2) variants leading to hyperinsulinism-polycystic kidney disease are associated with early-onset inflammatory bowel disease and gastric antral foveolar hyperplasia.
Kiparissi F, Dastamani A, Palm L, Azabdaftari A, Campos L, Gaynor E, Grünewald S, Uhlig HH, Kleta R, Böckenhauer D, Jones KDJ. Kiparissi F, et al. Hum Genet. 2023 May;142(5):697-704. doi: 10.1007/s00439-023-02523-7. Epub 2023 Feb 11. Hum Genet. 2023. PMID: 36773065 Free PMC article.
34 results